Search Results - "Pearl, Jeremy I"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Short-Term Immunosuppression Promotes Engraftment of Embryonic and Induced Pluripotent Stem Cells by Pearl, Jeremy I., Lee, Andrew S., Leveson-Gower, Dennis B., Sun, Ning, Ghosh, Zhumur, Lan, Feng, Ransohoff, Julia, Negrin, Robert S., Davis, Mark M., Wu, Joseph C.

    Published in Cell stem cell (04-03-2011)
    “…Embryonic stem cells (ESCs) are an attractive source for tissue regeneration and repair therapies because they can be differentiated into virtually any cell…”
    Get full text
    Journal Article
  2. 2

    Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles by Pearl, Jeremy I, Ma, Ting, Irani, Afraaz R, Huang, Zhinong, Robinson, William H, Smith, Robert L, Goodman, Stuart B

    Published in Biomaterials (01-08-2011)
    “…Abstract The inflammatory response to prosthetic implant-derived wear particles is the primary cause of bone loss and aseptic loosening of implants, but the…”
    Get full text
    Journal Article
  3. 3

    Pluripotent stem cells: immune to the immune system? by Pearl, Jeremy I, Kean, Leslie S, Davis, Mark M, Wu, Joseph C

    Published in Science translational medicine (12-12-2012)
    “…Human embryonic stem cells (hESCs), initially thought to be immune privileged cells, are now known to be susceptible to immune recognition. Human induced…”
    Get more information
    Journal Article
  4. 4

    In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation by Swijnenburg, Rutger-Jan, Schrepfer, Sonja, Cao, Feng, Pearl, Jeremy I, Xie, Xiaoyan, Connolly, Andrew J, Robbins, Robert C, Wu, Joseph C

    Published in Stem cells and development (01-12-2008)
    “…Embryonic stem cell (ESC)-based transplantation is considered a promising novel therapy for a variety of diseases. This is bolstered by the suggested…”
    Get more information
    Journal Article
  5. 5

    Timing of bone marrow cell delivery has minimal effects on cell viability and cardiac recovery after myocardial infarction by Swijnenburg, Rutger-Jan, Govaert, Johannes A, van der Bogt, Koen E A, Pearl, Jeremy I, Huang, Mei, Stein, William, Hoyt, Grant, Vogel, Hannes, Contag, Christopher H, Robbins, Robert C, Wu, Joseph C

    Published in Circulation. Cardiovascular imaging (01-01-2010)
    “…Despite ongoing clinical trials, the optimal time for delivery of bone marrow mononuclear cells (BMCs) after myocardial infarction is unclear. We compared the…”
    Get full text
    Journal Article
  6. 6